Company profile: Fluidic
1.1 - Company Overview
Company description
- Provider of tools for protein characterization, designing, developing and manufacturing instruments based on Microfluidic Diffusional Sizing (MDS) to analyze protein interactions in their native conditions without immobilization, delivering data on affinity, size and concentration.
Products and services
- Microfluidic Diffusional Sizing (MDS) Affinity Analysis: Engineers non-immobilizing assays to quantify protein interaction affinity, delivering precise binding metrics from diffusion-based measurements
- Microfluidic Diffusional Sizing (MDS) Concentration Measurement: Produces native-condition quantification of protein concentration by analyzing diffusional behavior, yielding accurate concentration data without immobilization
- Microfluidic Diffusional Sizing (MDS) Size Characterization: Constructs diffusion-based analyses to determine protein size in native conditions, reporting size metrics from microfluidic measurements without immobilization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fluidic
BioFlyte
HQ: United States
Website
- Description: Provider of biodefense solutions including BioTOF™ z200, a MALDI time-of-flight mass spectrometer for automatic collection and analysis of aerosol samples to detect biological and chemical threats in critical infrastructure; MailScreen™ z200, a mailroom workstation integrating BioTOF™ z200 for detecting hazardous biological powders in mail and parcels; and layered infrastructure protection with aerosol collection, automated handling, and AI/ML analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioFlyte company profile →
Nanotether Discovery Services
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical research technology developing innovative bio-chip technology, based in Cardiff, UK.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanotether Discovery Services company profile →
PathogenDx
HQ: United States
Website
- Description: Provider of RT-PCR and DNA microarray-based pathogen detection solutions, including assays for SARS-CoV-2 genes and variants (DetectX-Rv, DetectX-Cv), environmental SARS-CoV-2 screening (EnviroX-Rv), a UTI panel detecting 26 pathogens and 12 antibiotic resistance markers (D3 Array-UTI), and semi-quantitative fungal and bacterial assays (QuantX Fungal, QuantX Bacterial).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PathogenDx company profile →
Lipofabrik
HQ: France
Website
- Description: Provider of biological and biodegradable molecules produced through bioprocesses based on renewable resources, including lipopeptides such as Fengycin, Plipastatin, Iturin, Lichenysin, Mycosubtilin, and Surfactin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lipofabrik company profile →
Elegen
HQ: United States
Website
- Description: Provider of cell-free DNA synthesis solutions, including ENFINIA DNA producing long, complex linear DNA up to 7kb with 99.999% per-base accuracy, shipped in 6 to 8 business days; high-complexity DNA synthesis for challenging sequences like long repeats and GC-rich regions, with delivery as fast as 10 business days; and an Early Access Program for pre-commercial products, including sequences longer than 15,000 base pairs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elegen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fluidic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fluidic
2.2 - Growth funds investing in similar companies to Fluidic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fluidic
4.2 - Public trading comparable groups for Fluidic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →